JNJ loses Remicade US patent case on obviousness: http://finance.yahoo.com/news/johnson-johnson-announces-ruling-related-175400727.html The patent in question is 6,284,471 (http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6,284,471.PN.&OS=PN/6,284,471&RS=PN/6,284,471 ). JNJ will appeal the decision to the CAFC.